Home/Industries/Life Sciences Translation Services
Life Sciences Translation Services
From preclinical research and clinical trials to regulatory submissions, manufacturing and post-market surveillance, life sciences companies need accurate translations across the product lifecycle. Mediwords supports pharmaceutical, biotechnology, medical technology, diagnostics and CRO teams with specialized translators, independent revision and product-specific terminology in Canadian French and more than 30 languages.
Get a quote- One glossary
- Full lifecycle
- Native translators

Trusted by healthcare and life sciences organizations
Why Life Sciences Companies Treat Translation as a Lifecycle
One medicinal product, diagnostic test or medical device can generate clinical, regulatory, quality and commercial documentation for years. Life sciences translation connects those materials across languages and departments, so teams can work from consistent scientific terminology and traceable approved source text.
A study endpoint may appear in a protocol, investigator brochure, submission, medical publication and safety update. A device component can be described in its risk file, instructions for use and software interface. Inconsistent translations can trigger reviewer questions, slow updates or confuse readers—particularly when an approved term is replaced without context.
Mediwords specializes in medical, pharmaceutical and scientific translation. For ongoing accounts, we use product-specific glossaries and translation memories, coordinate subject-matter linguists across workstreams and record approved terminology changes for subsequent releases.
Translation Needs at Each Stage of the Product Lifecycle
What gets translated, and for whom, changes as a product advances:
| Stage | Typical documents | Who reads the translation |
|---|---|---|
| Discovery and preclinical | Study reports from partner labs, patent applications, collaboration summaries | Partners abroad, patent offices, investors |
| Clinical development | Protocols, investigator brochures, consent forms, patient questionnaires | Ethics boards, investigators, participants |
| Regulatory | Submission documents, responses to reviewers, labelling drafts | Health Canada, FDA and European reviewers |
| Manufacturing and quality | SOPs, batch records, certificates of analysis, validation reports | Plant staff, contract manufacturers, inspectors |
| Launch | Product monographs, packaging, sales training, medical information | Health professionals, pharmacists, patients |
| Post-market | Adverse event reports, safety letters, label updates, field notices | Regulators, health professionals, users |
Using approved references across stages reduces terminology drift. Each translation still requires review against the current source document and, where applicable, approval through your clinical, quality or regulatory process.
Requirements That Shape Life Sciences Translation for Canada and Export
Language and documentation requirements depend on the product, intended market, submission type and audience. These are examples that affect translation planning—not a substitute for product-specific regulatory advice:
- Canada, human drugs: Health Canada requires product information in the applicable official languages. Its June 20, 2025 notice sets conditional filing timelines for second-language product monographs and package-insert mock-ups. In some cases the second-language material can be supplied after authorization; other submissions still require it earlier. The notice does not change package-label requirements.
- Canada, medical devices: manufacturers of Class II, III and IV devices generally need an appropriate quality management system certificate issued through the Medical Device Single Audit Program (MDSAP). MDSAP does not itself mean every quality record must be translated; language needs depend on the document, audit context and applicable device labelling rules.
- United States: US drug labelling rules generally require specified information in English, subject to regulatory exceptions (21 CFR 201.15). Translations of source studies, supporting records and product information may also be needed for US stakeholders or submissions, depending on the project.
- European Union: medicinal product information and medical device documentation follow different regulatory frameworks. Required languages and approved wording depend on authorization route, member state and intended users; EMA templates are relevant to certain medicinal products, not every life sciences document.
Our role is accurate, terminology-controlled translation. Your regulatory, clinical and quality teams determine submission requirements, approve final content and authorize its use in each market.
Find the Page for Your Type of Company
Choose a specialist page for the documents, review workflows and terminology most relevant to your organization:
Pharmaceutical companies
Monographs, labelling, regulatory correspondence and safety documents for marketed and pipeline drugs.
Pharmaceutical translationBiotech companies
Investor documents, patents, CMC files from partners abroad and the first clinical trial.
Translation for biotech companiesMedtech companies
Market entry in Canada, the US and Europe, quality system documents, sales material and software.
Translation for medtech companiesContract research organizations
Multi-sponsor programs, vendor qualification and high volumes of study documents.
Translation for CROsWhat Changes When One Team Holds the Terminology
Fewer reviewer questions
Approved terms for active ingredients, endpoints and device components remain consistent across document types. Reviewers can focus on substance instead of unexplained wording differences.
Faster updates
When an approved source changes, translation memories help identify reusable text and changed segments. Each update is still checked in context, especially where warnings, indications or instructions have changed.
One confidentiality framework
Product documentation can be managed under an agreed confidentiality workflow, with NDA terms, controlled access and file-handling arrangements confirmed for each account.
Languages Across a Product's Life
English-to-Canadian-French translation is central to our work for the Canadian market, including regulated product information, instructions for use and medical communications. We also translate French source material into English for international research, manufacturing partners and publication. Clinical studies and patient programmes may require Spanish, Arabic, Punjabi, Tagalog, Chinese or other community languages, while global supply chains introduce additional European and Asian language pairs.
Mediwords supports more than 30 languages, subject to project scope and specialist availability. Qualified linguists translate into their native language and are assigned according to subject expertise, document purpose and intended audience.
One Term, Six Documents: How Inconsistency Creeps In
Take a single expression, such as the name of a dosage form, a device component or a study endpoint. Over the life of a product it appears in documents written by different teams, years apart:
| Document | Written by | Typical risk if translated in isolation |
|---|---|---|
| Protocol | Clinical operations | A literal rendering chosen under deadline becomes the de facto reference |
| Investigator brochure | Medical writing | A second translator picks a synonym that reads better |
| Regulatory submission | Regulatory affairs | Reviewers notice two names for one thing and ask why |
| Label and monograph | Labelling team | The approved term differs from the term used in the trial |
| Sales and training material | Marketing and training | Field teams use a third version with patients and clinicians |
| Safety reports | Pharmacovigilance or vigilance | Case narratives use whatever term the reporter used |
Not every variation is an error: a patient leaflet may legitimately use plainer wording than a regulatory submission. The objective is to preserve approved concepts, document audience-specific terminology and prevent unintended differences in meaning across versions.
What to Ask a Life Sciences Translation Supplier
Procurement and quality teams who qualify translation vendors usually check the same points. These are the answers you should expect, and the ones we give:
- Specialization: does the supplier work only in medical, pharmaceutical and scientific content, or is life sciences one sector among many?
- Translators: do they translate into their mother tongue, and are they assigned by subject rather than by availability?
- Revision: is every file revised by a second linguist, and is there a final check of numbers, units and terminology?
- Terminology control: can your team approve preferred terms, receive exports when agreed and track terminology decisions across product versions?
- Confidentiality: can the supplier review your NDA and define access, storage and retention arrangements before receiving sensitive records?
- Formats and certificates: can the supplier work in your templates and layout files, and issue a certificate of accuracy when an authority requires one?
Starting a Life Sciences Program With Mediwords
Programs usually start with one urgent file. We use it to set up what the next ones need:
- Reference set. You send the approved documents for the product: the latest label, monograph, protocol or IFU, in every language that exists.
- Product glossary. We extract terminology from source documents and any approved translations, then confirm preferred terms with your designated reviewers.
- Translation and revision. A native translator with the right specialty translates; a second linguist revises; a project manager checks numbers, units and terminology.
- Memory and updates. Approved translations can be added to a product-specific translation memory, with changes and applicable version references carried into the next assignment.
Our workflow is designed around ISO 17100 translation and independent revision principles; this does not represent a claim of third-party certification. See our quality process for more information.
Life Sciences Translation FAQ
What is life sciences translation?
Life sciences translation covers scientific, clinical, regulatory, quality, manufacturing and commercial documents used by pharmaceutical, biotechnology, medical device, diagnostics and research organizations throughout development and post-market activities.
Can you handle all departments of the same company?
Yes. Clinical operations, regulatory affairs, quality, manufacturing and medical affairs teams can coordinate projects through one account, with product-specific terminology and reference materials shared as appropriate.
Do you build and maintain a glossary for each product?
Yes. We create terminology lists from supplied references and approved translations, seek your team’s confirmation for preferred terms and update them as your documents and products evolve.
Which languages do life sciences companies ask for most?
Canadian French and English are important for Canadian and international work. Depending on the study population, market or supply chain, clients may also need Spanish, Arabic, Punjabi, Tagalog, Chinese, German and other languages. We support more than 30 languages, subject to project needs.
Can you work with our regulatory and quality templates?
Yes. We work with regulatory and quality templates, preserving headings, numbering, tables and cross-references where the source format allows. Your team reviews the final documents for submission or controlled use.
Do you sign confidentiality agreements before receiving data?
We can review and sign an appropriate non-disclosure agreement before you share confidential documents, and agree on file-handling and access requirements for the project.
Can you provide certificates of accuracy?
Yes. An agency certificate of accuracy is available on request. If a receiving authority requires a sworn, certified or otherwise specially qualified translator, we confirm those requirements and availability before accepting the assignment.
Will we own the glossary and translation memory?
We can maintain project-specific glossaries and translation memories and discuss export and ownership provisions in your agreement. Any deliverable or transfer rights should be confirmed in writing for your account.
Is your process aligned with a translation standard?
Our workflow incorporates ISO 17100 principles, including specialist translation and independent bilingual revision. This should not be interpreted as a claim of formal ISO certification.
Related Services
Get a Quote for Your Life Sciences Documents
Send us your documents, the product they belong to, the languages you need and your deadline. We reply within one business day with a fixed price and a delivery date. You can also write to us at info@mediwords.ca.